L'IA dans les environnements GxP : ce que tout responsable informatique pharmaceutique doit savoir
Lors de ce webinaire, le Dr Ajaz Hussain, ancien directeur adjoint de la U.S. FDA, explique ce qu'il faut réellement pour déployer l'IA de manière responsable dans des opérations pharmaceutiques réglementées.
With over three decades of experience spanning machine learning research, FDA policy development, and pharmaceutical quality systems, Dr. Hussain brings rare, first-hand authority to one of the most pressing questions facing pharma IT leaders today.
📌 What This Session Covers:
54% of pharma companies have no AI in GxP.
ML, GenAI, and Agentic AI are not the same thing in GxP, and confusing them could cost billions.
Most companies are stuck in compliance theater.
FDA issued a warning letter for AI-generated drug specs.
Before deploying AI in GxP, can you prove your people, processes, and products are stable?
_____________________________
Disclaimer: The views and opinions expressed in this episode are solely those of the guest and do not necessarily reflect the official policy or position of Pharma Now or any organisation they are affiliated with. This conversation is intended for informational and educational purposes only. We are here for honest, unfiltered conversations that move the industry forward.
Vos intervenants
Recevez une invitation d'agenda dès qu'un webcast est annoncé.
Un court e-mail par session — titre, intervenants et un ajout au calendrier en un clic.Nothing else.